|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,565.00 ARS | -1.88% |
|
-1.57% | -20.76% |
| Market Cap | 126B 88.16M 75.98M 69.96M 65.69M 123M 8.34B 125M 827M 322M 4.08B 331M 324M 14.15B | P/E Ratio 2024 |
6.08x | P/E Ratio 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 357B 249M 215M 198M 186M 349M 23.57B 352M 2.34B 911M 11.54B 936M 916M 40B | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | -1.88% | ||
| 1 week | -1.57% | ||
| Current month | -4.57% | ||
| 1 month | -1.88% | ||
| 3 months | -9.01% | ||
| 6 months | -24.76% | ||
| Current year | -20.76% |
| 1 week | 1,530 | 1,640 | |
| 1 month | 1,520 | 1,725 | |
| Current year | 1,420 | 2,130 | |
| 1 year | 945 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 208.5 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 2025-04-28 | |
| Corporate Officer/Principal | - | 2025-04-28 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.88% | -1.57% | +7.93% | +205.07% | 88.16M | ||
| -0.61% | -1.94% | +39.00% | +150.72% | 1,001B | ||
| -0.20% | -0.77% | +51.51% | +43.20% | 566B | ||
| +0.40% | -1.31% | +16.56% | +60.47% | 393B | ||
| +0.64% | +2.29% | +24.04% | +16.53% | 326B | ||
| +0.38% | +0.97% | +25.77% | +32.31% | 276B | ||
| +0.77% | -0.64% | +25.47% | +14.87% | 277B | ||
| +4.07% | +3.83% | -39.76% | -45.71% | 193B | ||
| -0.77% | +0.95% | +17.69% | +51.46% | 188B | ||
| +2.36% | +1.38% | +14.80% | +61.34% | 158B | ||
| Average | +0.36% | +0.16% | +18.30% | +59.03% | 337.69B | |
| Weighted average by Cap. | +0.36% | -0.41% | +28.04% | +67.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 91.79B 64.03M 55.19M 50.82M 47.71M 89.58M 6.05B 90.53M 600M 234M 2.96B 240M 235M 10.27B | 127B 88.4M 76.19M 70.15M 65.87M 124M 8.36B 125M 829M 323M 4.09B 332M 325M 14.18B |
| Net income | 23.85B 16.63M 14.34M 13.2M 12.39M 23.27M 1.57B 23.52M 156M 60.77M 770M 62.43M 61.1M 2.67B | 3.09B 2.15M 1.86M 1.71M 1.6M 3.01M 204M 3.05M 20.2M 7.87M 99.73M 8.08M 7.91M 346M |
| Net Debt | 134B 93.23M 80.35M 73.99M 69.47M 130M 8.81B 132M 874M 341M 4.32B 350M 342M 14.96B | 231B 161M 139M 128M 120M 225M 15.24B 228M 1.51B 589M 7.46B 605M 592M 25.86B |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 1,565.00 $ | -1.88% | 4,012 |
| 26-06-12 | 1,595.00 $ | -1.85% | 2,362 |
| 26-06-11 | 1,625.00 $ | +1.88% | 2,208 |
| 26-06-10 | 1,595.00 $ | +0.31% | 5,402 |
| 26-06-09 | 1,590.00 $ | -0.31% | 35,894 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















